Conference item icon

Conference item : Abstract

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Sub department:
CRUK/MRC Ox Inst for Radiation Oncology
Role:
Author
Publisher:
Society of Nuclear Medicine Publisher's website
Journal:
Journal of Nuclear Medicine Journal website
Volume:
57
Issue:
S2
Article number:
333
Host title:
Journal of Nuclear Medicine
Publication date:
2016-05-01
EISSN:
2159-662X
ISSN:
0161-5505
Source identifiers:
917722
Subtype:
Abstract
Pubs id:
pubs:917722
UUID:
uuid:84b0b253-661b-48b6-926b-3910c8d715fc
Local pid:
pubs:917722
Deposit date:
2018-10-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP